))
“You Just Have to Keep Buying”: How Diet Culture Profits from Fatphobia
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on January 22, 2025 05:25 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 462387837 series 3319851
Вміст надано Money with Katie and Morning Brew. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Money with Katie and Morning Brew або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Welcome back to Part Two of our series, the Economics of Weight Loss Drugs. (If you haven’t heard Part One, listen here!)
Today, we’re picking back up where we left off in our conversation with Lili Zarghami, a writer who got on (then off) a weight loss drug. Then we’ll talk with Dr. Mara Gordon, a weight-neutral physician who deals with GLP-1s. Finally, I’ll share my final thoughts and analysis on where the world of GLP-1 agonists is all headed and what it says about health, wealth, stigma, and class.
Transcripts, show notes, production credits, and more can be found at: https://moneywithkatie.com/diet-culture.
Money with Katie’s mission is to be the intersection where the economic, cultural, and political meet the tactical, practical, personal finance education everyone needs.
Learn more about your ad choices. Visit megaphone.fm/adchoices
259 епізодів
Поширити
